Breast Journal

Papers
(The TQCC of Breast Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Breast Cancer Epidemiology and Survival Analysis of Shenyang in Northeast China: A Population-Based Study from 2008 to 201744
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective S35
“Going Flat” in Nipple‐Sparing Mastectomy—An Analysis of Patient‐Reported Outcome Measurements of Preliminary 57 Procedures31
Mastitis and Mammary Abscess Management Audit (MAMMA): A Survey of Patients’ Perspective on the Management of Mammary Abscesses in the UK27
Brain Metastasis in Triple‐Negative Breast Cancer22
20
Unveiling miRNA30b’s Role in Suppressing ADAM12 to Combat Triple‐Negative Breast Cancer17
Efficacy of Presurgical Short‐Term Endocrine Therapy During the Waiting Period for Surgery in Postmenopausal Hormone Receptor‐Positive Breast Cancer17
Treatment Regimens and Response Rates in Early TNBC: A Review of Real‐World Practice in the Second Decade of the 21st Century14
Corrigendum to “Primary bilateral breast lymphoma in an elder male patient”11
Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study11
Application of Microwave Ablation Combined With Chai Hu Qing Gan Tang in the Treatment of Idiopathic Granulomatous Mastitis11
Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer10
Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy10
Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients10
LncRNA FAM225B Regulates PDIA4-Mediated Ovarian Cancer Cell Invasion and Migration via Modulating Transcription Factor DDX1710
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk8
The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience8
OGT‐Mediated O‐GlcNAcylation Stabilizes c‐Myc Activity and Promotes Chemoresistance in Triple‐Negative Breast Cancer7
Clinical Radiologic Analysis of 2964 Papillary Breast Lesions7
Axillary Recurrence After a Negative Sentinel Lymph Node Biopsy (SLNB) for Initial Positive Node Breast Cancer Postneoadjuvant Therapy: Insights From a Systematic Review and Meta‐Analysis7
Defining Multiple Fibroadenomas: A Systematic Review of Clinical Characteristics and Management7
Nerve Grafts in Breast Reconstruction: A Narrative Review7
Development of the Breast Surgical Oncology Fellowship in the United States6
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers6
Switching to Tumescent Dissection in Mastectomy6
Extratumoral Signs of Malignant Nonspiculate and Noncalcified Masses on Mammography: Are They Associated With Prognostic Factors in Breast Cancer?5
Examining the Role of Matrix Metalloproteinase‐2 and MicroRNAs Regulation in Breast Cancer5
Symptom Clusters in Brazilian Women With Stage I and Stage III Nonmetastatic Breast Cancer: A Cross‐Sectional Study5
Single‐Port Three‐Dimensional Endoscopic‐Assisted Axillary Lymph Node Dissection (S‐P 3D E‐ALND): Surgical Technique and Preliminary Results4
MLLT11 siRNA Inhibits the Migration and Promotes the Apoptosis of MDA-MB-231 Breast Cancer Cells4
Diagnosis of Benign and Malignant Newly Developed Nodules on the Surgical Side After Breast Cancer Surgery Based on Machine Learning4
Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2‐Positive Breast Cancer4
Selected Pathological Criteria That Predict Low Rates of Axillary Lymph Node Metastases Regardless of Patient Age: A Single Institution Study4
Duration of Breastfeeding and Risk Reduction of Breast Cancer among Mothers Who Have Ever Breastfed: A Case‐Control Study Conducted in Bahir Dar, Ethiopia4
Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer4
Effectiveness of Duct Excision Procedures in Detecting Preneoplastic and Malignant Lesions in Pathological Nipple Discharge: A Retrospective Cohort Study4
Catheter Tip Migration in Female Patients With Breast Cancer: A Retrospective Comparative Study of Right‐ and Left‐Sided Chest Ports4
MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study3
Efficacy and Tolerability of Methotrexate for Idiopathic Granulomatous Mastitis: A Systematic Review and Meta‐Analysis3
NOTIFICATION: The Role of Pathologists in Recognition of Morphologic and Biologic Features of Genetically Mutated Breast Cancer3
NOTIFICATION: Is it Ductal Carcinoma in Situ with Microinvasion or “Ductogenesis”? The Role of Myoepithelial Cell Markers3
The Relationship Between Clinicopathological Features and Prognosis of 22 Cases of Tubular Breast Carcinoma3
Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes3
Clinical Characteristics and Independent Risk Factors for Pathologic Nipple Discharge of 375 Cases3
Morphological Assessment of Breast Lesions With Type 2 Dynamic Curves Using DWI and T2WI Based on Breast Imaging Reporting and Data System Lexicon Descriptors3
Programmed Death Ligand 1 (PDL1) Expression in Neoadjuvant Triple‐Negative Breast Cancer: Association With Chemotherapy Response and Residual Cancer Burden3
Rare Histological Types of Breast Cancer: A Single‐Center Experience3
Idiopathic Granulomatous Mastitis3
Tyrer–Cuzick Lifetime Risk Is Not Associated With Non‐BRCA1/2 Pathogenic Variants for Breast Carcinoma3
Causes of Unwarranted Variation and Disparity in Breast Cancer Management in Regional and Rural Area3
Corrigendum to “The Quest for Outpatient Mastectomy in COVID‐19 Era: Barriers and Facilitators”3
Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study3
Evaluating YouTube Videos With Prophylactic Mastectomy Content in Terms of Their Quality and Reliability3
The Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinoma3
0.24686217308044